On Tuesday, August, 4th, in the Auditorium hall of the New Corporative Building of Grupo Sancor Seguros in Sunchales, took place a dissertation about the discovery of new drugs for the treatment of cancer. This event was directed by Osvaldo Podhajcer, PhD in Biological Sciences and it was organized by CITES and Prevención Salud, the prepaid medicine company of Grupo Sancor Seguros.
During his presentation, Dr. Podhajcer talked about the development of treatments for cancer based in modified virus. It is important to remark that the speaker is a High Level Researcher in CONICET, he has been director since 1997 of the Cellular and Molecular Therapy Laboratory of Instituto Leloir and has received many prizes among which we highlight the Fundación Konex prize (2003) as one of the most prominent Argentine scientists of the decade in biomedical areas.
“In Prevención Salud and CITES, we have a commitment with the wellbeing of people, thus, with the support and diffusion of every advancement that may rise life quality for people. In this sense, we thought it would be absolutely important to carry out this presentation with such a renowned professional in the field of medic science as Dr. Podhajcer, international referent in the areas of cancer and genetic therapy”, people from Grupo Sancor Seguros said.